Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment. (Q38980782)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

author name string

Ze Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Min Xiong

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yan Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nan Bai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yunping Luo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Luyuan Li

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yuquan Wei

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Yanhua Liu

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Xiaoyue Tan

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Rong Xiang

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

language of work or name

0 references

publication date

27 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Nature Communications

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

4280

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

Layer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Drug penetration in solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Supramolecular drug-delivery systems based on polymeric core-shell architectures

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Polymer nanocompartments in broad-spectrum medical applications

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Progress in microRNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Cell-penetrating peptides: breaking through to the other side

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

The tumor microenvironment: a target for combination therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Targeting tumor-associated macrophages as a novel strategy against breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

A Legumain-based minigene vaccine targets the tumor stroma and suppresses breast cancer growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Asparagine endopeptidase is required for normal kidney physiology and homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Peptide-based MRI contrast agent and near-infrared fluorescent probe for intratumoral legumain detection

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Effects of legumain as a potential prognostic factor on gastric cancers

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Functional imaging of legumain in cancer using a new quenched activity-based probe

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

The Legumain Protease‐Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Current trends in the use of liposomes for tumor targeting

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Cationic TAT peptide transduction domain enters cells by macropinocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Alginic acid-coated chitosan nanoparticles loaded with legumain DNA vaccine: effect against breast cancer in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

21 January 2018

Design and Synthesis of Novel Functional Lipid-Based Bioconjugates for Drug Delivery and Other Applications

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

7 January 2021

based on heuristic

inferred from DOI database lookup

Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS5280

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NCOMMS5280

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

2014NatCo...5.4280L

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24969588%20AND%20SRC:MED&resulttype=core&format=json

21 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38980782&oldid=2202415599"